Ascites do not affect the rate of complete cytoreductive surgery and prognosis in patients with primary ovarian cancer with ascites treated with hyperthermic intraperitoneal chemotherapy-Reference-Cited by-同舟云学术

Ascites do not affect the rate of complete cytoreductive surgery and prognosis in patients with primary ovarian cancer with ascites treated with hyperthermic intraperitoneal chemotherapy

Published:2019-06-19 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Ba Mingchen¹,Long Hui²,Zhang Xiangliang¹,Yan Zhaofei¹,Wang Shuai¹,Wu Yinbing¹,Gong Yuanfeng¹,Cui Shuzhong³

Affiliation:

1. Intracelom Hyperthermic Perfusion Therapy Center, Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, Guangdong 510095, P.R. China

2. Guangzhou Dermatology Institute, Guangzhou, Guangdong 510095, P.R. China

3. Guangzhou Baorui Medical Technology Co., Ltd. Guangzhou, Guangdong 510540, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and feasibility of hyperthermic intraperitoneal chemotherapy during interval cytoreductive surgery in patients with advanced high‐grade serous ovarian, fallopian tube, peritoneal cancer in an Australian context;Australian and New Zealand Journal of Obstetrics and Gynaecology;2023-05-31

2. Malign asitli over kanserinde sitoredüktif cerrahide perioperatif hemodinamik optimizasyon;Cukurova Medical Journal;2022-09-30

3. Prognostic factors associated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in recurrent ovarian cancer;International Journal of Gynecology & Obstetrics;2020-10-28

4. Cisplatin/docetaxel;Reactions Weekly;2019-08